Immunotherapy First or After Nintedanib?: A Spanish Experience

被引：1

作者：

Cruz, P. ^{[1
]}

Gutierrez Sainz, L. ^{[1
]}

Aguado, C. ^{[2
]}

Antonanzas, M. ^{[2
]}

Mielgo, X. ^{[3
]}

Cabezon, L. ^{[4
]}

Chara, L. E. ^{[5
]}

Gomez-Barreda, I. ^{[5
]}

Martinez Moreno, E. ^{[6
]}

Lage Alfranca, Y. ^{[7
]}

Velastegui, A. ^{[8
]}

Sotelo, M. ^{[9
]}

Garcia Rueda, A. ^{[10
]}

Olmedo, M. E. ^{[10
]}

Martinez Recio, S.

De Castro Carpeno, J. ^{[1
]}

机构：

[1] La Paz Univ Hosp, Dept Oncol, Madrid, Spain

[2] Clin San Carlos Hosp, Dept Oncol, Madrid, Spain

[3] Fdn Alcorcon Hosp, Dept Oncol, Madrid, Spain

[4] Torrejon Univ Hosp, Dept Oncol, Madrid, Spain

[5] Hosp Univ Guadalajara, Dept Med Oncol, Guadalajara, Spain

[6] Virgen de La Salud Hosp, Dept Oncol, Toledo, Spain

[7] Univ Hosp, Fdn Jimenez Diaz, Dept Oncol, Madrid, Spain

[8] Mostoles Univ Hosp, Dept Oncol, Madrid, Spain

[9] Fuenlabrada Univ Hosp, Dept Oncol, Madrid, Spain

[10] Ramon & Cajal Univ Hosp, Dept Oncol, Madrid, Spain

来源：

关键词：

non-small cell lung cancer; nintedanib; immunotherapy;

D O I：

10.1016/j.jtho.2019.08.1398

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.01-55

引用

页码：S660 / S661

页数：2